Literature DB >> 10915859

Humanization of a mouse monoclonal antibody neutralizing TNF-alpha by guided selection.

Z Wang1, Y Wang, Z Li, J Li, Z Dong.   

Abstract

With the advent of phage display antibody libraries, humanization of murine antibodies can be achieved by epitope guided selection. In present study, guided selection was applied to the humanization of the mouse mAb Z8 that is directed to human TNF-alpha and can neutralize the cytotoxicity of TNF-alpha. First, the Z8 Fd gene was paired as a template with a repertoire of human kappa chains, and displayed on the filamentous phage, forming a hybrid phage antibody library. Selected by four rounds of panning against TNF-alpha, hybrid antibody fragments that bound to TNF-alpha and contained human kappa chains were obtained. Meanwhile human Fd genes were selected by pairing the human Fd repertoire with the Z8 kappa chain and performing the same procedure of panning. One of the isolated human Fd genes (huFd2), which showed the strongest reactivity, was chosen to pair with 12 of selected human kappa chains. Two of the resulting human Fabs (huFd2-hukappa1 and huFd2-hukappa2), with same Fd and different kappa chains, bound to TNF-alpha specifically. Their human origin was proved by ELISA and sequencing analysis. The human Fabs competitive ELISA and in vitro TNF-alpha neutralization assay demonstrated that the human Fabs resembled its parental mouse mAb Z8 in that they both recognized the same epitope and neutralized the cytotoxicity of TNF-alpha. These results suggest that guided selection is a promising strategy in murine mAb humanization.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10915859     DOI: 10.1016/s0022-1759(00)00203-9

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  7 in total

1.  Conversion of a murine monoclonal antibody A13 targeting epidermal growth factor receptor to a human monoclonal antibody by guided selection.

Authors:  Ki Hwan Chang; Min Soo Kim; Gwang Won Hong; Yong Nam Shin; Se Ho Kim
Journal:  Exp Mol Med       Date:  2012-01-31       Impact factor: 8.718

Review 2.  The Use of Bacteriophages in Biotechnology and Recent Insights into Proteomics.

Authors:  Ana G Abril; Mónica Carrera; Vicente Notario; Ángeles Sánchez-Pérez; Tomás G Villa
Journal:  Antibiotics (Basel)       Date:  2022-05-13

3.  Blockade of autoantibody-initiated tissue damage by using recombinant fab antibody fragments against pathogenic autoantigen.

Authors:  Gang Wang; Hideyuki Ujiie; Akihiko Shibaki; Wataru Nishie; Yasuki Tateishi; Kazuhiro Kikuchi; Qiang Li; James R McMillan; Hiroshi Morioka; Daisuke Sawamura; Hideki Nakamura; Hiroshi Shimizu
Journal:  Am J Pathol       Date:  2009-12-30       Impact factor: 4.307

4.  Generation of a high-fidelity antibody against nerve growth factor using library scanning mutagenesis and validation with structures of the initial and optimized Fab-antigen complexes.

Authors:  Sherry L La Porte; Charles Eigenbrot; Mark Ultsch; Wei-Hsien Ho; Davide Foletti; Alison Forgie; Kevin C Lindquist; David L Shelton; Jaume Pons
Journal:  MAbs       Date:  2014 Jul-Aug       Impact factor: 5.857

5.  Production of Antigen-Binding Fragment against O,O-Diethyl Organophosphorus Pesticides and Molecular Dynamics Simulations of Antibody Recognition.

Authors:  Zi-Jian Chen; Xuan Zhang; Bing-Feng Wang; Mei-Fang Rao; Hong Wang; Hong-Tao Lei; Hui Liu; Yan Zhang; Yuan-Ming Sun; Zhen-Lin Xu
Journal:  Int J Mol Sci       Date:  2018-05-06       Impact factor: 5.923

Review 6.  Phage Display Technology as a Powerful Platform for Antibody Drug Discovery.

Authors:  Kazuya Nagano; Yasuo Tsutsumi
Journal:  Viruses       Date:  2021-01-25       Impact factor: 5.048

7.  Substitution of Heavy Complementarity Determining Region 3 (CDR-H3) Residues Can Synergistically Enhance Functional Activity of Antibody and Its Binding Affinity to HER2 Antigen.

Authors:  Seung Kee Moon; So Ra Park; Ami Park; Hyun Mi Oh; Hyun Jung Shin; Eun Ju Jeon; Seiwhan Kim; Hyun June Park; Young Joo Yeon; Young Je Yoo
Journal:  Mol Cells       Date:  2016-01-07       Impact factor: 5.034

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.